Radiation could cause breast cancer

Washington, May 14 (ANI): In a study on cultures of human breast cells, researchers have discovered that radiation exposure can alter the environment surrounding the cells so that future cells are more likely to become cancerous.

Already, it is known that exposure to ionizing radiation can result in mutations or other genetic damage that cause cells to turn cancerous.

“Our work shows that radiation can change the microenvironment of breast cells, and this in turn can allow the growth of abnormal cells with a long-lived phenotype that has a much greater potential to be cancerous,” says Paul Yaswen, a cell biologist and breast cancer research specialist with Berkeley Lab”s Life Sciences Division.

Studies have shown that if a cell develops a pre-cancerous phenotype, it can pass on these “epigenetic” changes to its daughters, just as it can pass on genetic mutations.

“Many in the cancer research community, especially radiobiologists, have been slow to acknowledge and incorporate in their work the idea that cells in human tissues are not independent entities, but are highly communicative with each other and with their microenvironment. We provide new evidence that potential cancer agents and their effects must be evaluated at a systems level,” said Yaswen.

“The work we did was performed with non-lethal but fairly substantial doses of radiation, unlike what a woman would be exposed to during a routine mammogram. However, the levels of radiation involved in other procedures, such as CT scans or radiotherapy, do start to approach the levels used in our experiments and could represent sources of concern,” said Yaswen.

For the study, researchers worked with human mammary epithelial cells (HMECs), the cells that line breast ducts, where most breast cancers begin.

In a culture dish, the vast majority of breast cells display a phenotype that allows them to divide between five and 20 times before becoming senescent.

However, also present are rare variant HMECs, which display a phenotype that allows them to continue dividing for many weeks in culture.

This vHMEC phenotype arises spontaneously and is much more susceptible to malignancy because it lacks a tumor-suppressing protein called p16.

To test the effects of radiation on cellular environment and subsequent cell behavior, the research team grew sets of HMECs from normal breast tissue in culture dishes for about a week, then exposed each set to a single treatment of a low-to-moderate dose of radiation.

They then compared the irradiated sets to sets of breast cells that were not irradiated.

Four to six weeks after the radiation treatments, most of the cells in both the irradiated and unirradiated sets had permanently stopped dividing.

“However, the daughters of breast cells exposed to radiation formed larger, more numerous patches of cells with the vHMEC phenotype than did the daughters of the unirradiated cells. An agent-based model developed by Sylvain Costes and Mary Helen Barcellos-Hoff suggests that the radiation increased the rate at which short-lived cells became senescent,” said Yaswen.

In a culture dish, breast cells will only divide and grow so long as there is room for daughter cells to spread out.

When the dish becomes full, the cells stop dividing. By promoting premature senescence in the normal HMEC, the radiation treatments accelerated the outgrowth of the vHMECs.

“Radiation exposure did not directly induce new vHMECs and the effect was not dose-dependent in the dose range we investigated. However, by getting normal cells to prematurely age and stop dividing, the radiation exposure created space for epigenetically altered cells that would otherwise have been filled by normal cells. In other words, the radiation promoted the growth of pre-cancerous cells by making the environment that surrounded the cells more hospitable to their continued growth,” said Yaswen.

The study appears in the on-line journal Breast Cancer Research. (ANI)

Veggies, whole grains could encourage cancer growth in some cases

Washington, Aug 20 (ANI): A new study has cast doubt on the cancer-fighting power of antioxidants- found in many vegetables and whole grains – by showing that they can also help cancer cells to survive and thrive in some situations.

Antioxidants have previously been found to prevent the formation of tumours by preventing free radicals, or highly reactive molecules, from causing DNA damage.

Now, scientists have shown that antioxidants may have the opposite effect in human breast cells.

In the new study, antioxidants behaved like cancer-causing agents, protecting cells that should otherwise have died-which allowed them to multiply and become cancerous.

“The survival of these cells could be contributing to [tumour creation], rather than the opposite,” National Geographic News quoted study leader Zachary Schafer of the University of Notre Dame in Indiana as saying.

Schafer and a team at Harvard Medical School cultured breast-tissue cells using simulated scaffolding that mimics how cells grow in the body.

The cells formed a spherical structure that became hollowed out as the cells in the center detached from the cells on the scaffolding and died.

However, when the researchers introduced a cancer gene into the mix, the detached cells did not die-just as happens in the body.

“This happens in early breast cancer lesions,” said Schafer.

Meanwhile, the researchers noticed that the normal, detached cells without the cancer gene were being damaged by naturally occurring free radicals.

Also, the detached cells were not producing enough ATP, a critical energy molecule.

The researchers added high concentrations of antioxidants to the cell culture in an effort to suppress the harmful free radicals and boost ATP production.

They found that antioxidants have exactly the same effect as the cancer gene: The detached cells did not die.

This is because the antioxidants are helping the cells recover their ability to produce ATP, Schafer said. The cancer gene also restored ATP production in the cells.

The researchers, however, insist that the findings should not alarm cancer patients as the research is laboratory based and the results may not replicate in people.

The study has been reported online in the journal Nature. (ANI)

Soon, breastmilk test to detect early breast cancer risk

Washington, Apr 4 (ANI): Nursing mothers’ breast milk might one day help assess future breast cancer risk, say researchers.

A research team led by environmental toxicologist Kathleen Arcaro of the University of Massachusetts Amherst will be conducting a series of experiments to identify methylated genes that indicate potentially pre-cancerous changes in breast cells.

The test could show signs of elevated breast cancer risk in women at an earlier age than ever before.

Methylation pushes cells toward cancer development because they represent potential tumour sites.

Early detection of methylation in breast tissue is a key in preventing cancer.

Arcaro suggests that current detection techniques such as ductal lavage and nipple aspiration yield very few cells, only tens or hundreds rather than the millions available from collecting breastmilk.

Also, breastmilk contains what Arcaro calls “a survey of cells from all the glands in the breast”.

This significantly extends the reach of the risk assessment to many more breast tissues than other methods.

Because breast cancer in young women is rare, Arcaro says, “the main advantage many women will get from our new test based on breast milk samples will be peace of mind.”

However, those few who are at elevated risk will find it out “far, far earlier than ever before,” and the early warning should allow them to choose treatment options. (ANI)

Naturally fluorescent molecule may act as cancer indicator

Washington, April 3 (ANI): Penn State researchers say that a naturally fluorescent molecule found in all living cells may serve as an indicator of cancer.

Ahmed Heikal, associate professor of bioengineering, points out that nicotinamide adenine dinucleotide (NADH) fuels a series of biochemical reactions that involve various enzymes to produce ATP, the major energy source in cells.

In the event of disease or a metabolic disorder, he adds, these enzymes and their related reactions can become disabled, causing a build-up of unused NADH.

Heikal says that one of the main challenges in cancer diagnosis is the ability to differentiate cancer cells from normal ones at the early stages of tumour progression.

His team teased apart the critical difference between normal and cancerous cells by using the fluorescence of natural NADH.

Combining the state-of-the-art spectroscopy and microscopy techniques, he and his colleagues were able to convert such fluorescence into an accurate measure of NADH concentration in live cells.

Heikal and graduate student Yu have found that the average concentration of NADH in breast cancer cells is about twice that in normal breast cells.

“If we are given two live cells, one normal and the other cancerous, we could differentiate between the two with confidence,” said Heikal.

“For the first time, we have been able to quantify the concentration of NADH in both live breast cells and breast cancer cells,” he added.

The research team also looked at the amounts of NADH in the cell that is free and how much is bound to other enzymes. The amounts were found to be different in normal and cancer cells.

“We realized that the fluorescence intensity not only depends upon the concentration of NADH but also on its structure — free or enzyme-bound — as well as its place inside the cell — in the cytoplasm (non-nucleus part of the cell) or in mitochondria,” said Heikal.

“Since a free NADH molecule would rotate — tumble — faster than enzyme-bound NADH, we were able to develop a technique called rotational diffusion imaging to establish a direct measure of the concentrations of free and enzyme-bound NADH throughout a living cell, whether in the cytosol (cell fluid) or the mitochondria,” he added.

Heikal and Yu confirmed that disruption of chemical reactions that produce ATP could lead to an increase in NADH by exposing normal breast cells to potassium cyanide, a known inhibitor of some of these critical mitochondrial enzymes.

They found that the NADH concentration in the normal cells increased when exposed to potassium cyanide. The relative amounts of NADH in the mitochondria also rose significantly.

While previous studies measured the amount of NADH in cells using conventional biochemical techniques that require destroying the cells, Heikal believes that measurements of dead cells may not be accurate or relevant for diagnostic or clinical use.

“The advantage of our non-destructive approach is that the NADH location in a cell relates to its function in cell survival,” he said.

“When you destroy the cell, you do not know where the NADH molecules existed inside the cell and what role they might have played in cell survival. For accurate diagnosis, you need to have the cellular context to better understand the problem,” he added.

He is of the opinion that the ability to accurately measure NADH levels in a cell without killing it could have potential implications for related research on human health and drug delivery.

“Our technique is not limited to detecting cancer. Other neurodegenerative diseases related to mitochondrial anomalies can also be detected with our method,” Heikal said.

“We can also use our approach to quantify the efficiency of a new drug on manipulating the activities of mitochondrial enzymes associated with energy production in cells,” he added.

The findings of the study have been published in the Journal of Photochemistry and Photobiology B: Biology. (ANI)